CURRENT USE OF TOTALLY IMPLANTABLE VENOUS ACCESS PORTS IN PATIENTS WITH HEAD AND NECK CANCER RECEIVING CHEMOTHERAPY AT NGHE AN ONCOLOGY HOSPITAL
Main Article Content
Abstract
Objectives: To describe the clinical characteristics and evaluate the use of totally implantable venous access ports in patients with head and neck cancer receiving chemotherapy.
Materials and methods: A prospective descriptive study was conducted on 35 patients with head and neck cancer who were indicated for chemotherapy and underwent totally implantable venous access port insertion at the Department of Medical Oncology I, Nghe An Oncology Hospital, from 03/ 2025 to 08/2025. Outcome measures included complications, port functionality, pain severity, adherence to the nursing care protocol, and patient satisfaction.
Result: The mean age of the participants was 61.03 ± 7.9 years, and all patients were male. Hypopharyngeal - laryngeal cancer was the most common primary tumor site (57.1%), and the majority of patients were diagnosed at stage III–IV (94.3%). Port implantation was performed before the initiation of chemotherapy in 77.1% of patients, and 94.3% of the catheters were inserted via the right internal jugular vein. Pain during port access was generally mild, with 71.4% of patients reporting a Visual Analog Scale (VAS) score of 2. Adherence to the standardized nursing care protocol was achieved in 91.4% of cases. The complication rate was low, including one case of local infection (2.9%) and one case of catheter occlusion (2.9%). Adherence to the nursing care protocol was significantly associated with a lower complication rate (p = 0.005). Overall, 74.3% of patients reported being satisfied or very satisfied with the implanted port.
Conclusion: Totally implantable venous access ports demonstrated a low complication rate, good port functionality, mild pain, and high patient satisfaction in patients with head and neck cancer receiving chemotherapy. Adherence to standardized nursing care protocols was associated with a significantly lower rate of port-related complications.
Article Details
Keywords
Head and neck cancer, Totally implantable venous access port, Nghe An Oncology Hospital.
References
2. Nickel B., Gorski L., Kleidon T. và cộng sự. (2024). Infusion Therapy Standards of Practice, 9th Edition. J Infus Nurs, 47(1S Suppl 1), S1–S285.
3. Lê Văn Long, Hoàng Công Tùng, và Nguyễn Thanh Hùng (2023). Đánh giá kết quả sử dụng buồng tiêm truyền để truyền hoá chất cho bệnh nhân ung thư tại Bệnh viện Bạch Mai. Số 134 (06-2023), 54–60.
4. Nguyễn Thị Vượng, Phạm Duy Mạnh, và Trần Trung Bách (2025). Đánh giá tính an toàn và chất lượng sống của bệnh nhân ung thư điều trị hoá chất qua buồng tiêm truyền tại Bệnh viện Đại học Y Hà Nội. Tạp chí Y học Việt Nam, 553 (số 1), 194–198.
5. Hawker G.A., Mian S., Kendzerska T. và cộng sự. (2011). Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP). Arthritis Care Res (Hoboken), 63 Suppl 11, S240-252.
6. Trương Thị Hoàng Ny, Nguyễn Thị Hồng Chuyên, Hà Thanh Thanh và cộng sự. (2024). Kết quả đặt buồng tiêm tĩnh mạch dưới da (Port-a-cath) trên bệnh nhân ung thư. Tạp Chí Y Dược Huế, 14 (số 7), 116–120.
7. Broadhurst D., Cooke M., Sriram D. và cộng sự. (2023). International Consensus Recommendation Guidelines for Subcutaneous Infusions of Hydration and Medication in Adults. J Infus Nurs, 46(4), 199–209.